Table 1. Clinical characteristics of 531 patients with cervical cancer treated with lymph node dissection.
| Characteristic | Value |
|---|---|
| Age (yr) | 46 (21–79) |
| FIGO stage | |
| Ia | 28 (5.3) |
| Ib1 | 255 (48.0) |
| Ib2 | 53 (10.0) |
| IIa | 14 (2.6) |
| IIb | 145 (27.3) |
| III | 22 (4.1) |
| IV | 14 (2.6) |
| Tumor histology | |
| Squamous cell carcinoma | 346 (65.2) |
| Adenocarcinoma | 132 (24.9) |
| Adenosquamous carcinoma | 42 (7.9) |
| Others | 11 (2.1) |
| Chemotherapy before surgery | |
| No | 441 (83.1) |
| Yes | 90 (16.9) |
| Parametrial involvement | |
| Negative | 361 (68.0) |
| Positive | 158 (29.8) |
| Not available | 12 (2.3) |
| Lymph node metastasis | |
| Negative | 386 (72.7) |
| Positive | 145 (27.3) |
| Sentinel lymph node biopsy | |
| Not performed | 416 (78.3) |
| Performed | 115 (21.7) |
| Para-aortic lymphadenectomy | |
| Not performed | 291 (54.8) |
| Performed | 240 (45.2) |
| No. of lymph nodes removed | |
| Total | 48 (1–143) |
| Pelvic lymph node | 44 (1–126) |
| Para-aortic lymph node | 0 (0–64) |
Values are presented as median (range) or number (%).
FIGO, International Federation of Gynecology and Obstetrics.